drugset / Trial / NCT02744417

Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy

NCT02744417

Completed 63 enrolled Claudio Mendes Pannuti
NaSingle-groupOpen-labelTreatment

Summary

The aim of this prospective interventional study is to verify the efficacy of smoking cessation on clinical and microbiological outcomes of non-surgical periodontal therapy of chronic periodontitis patients. Smokers willing to quit received periodontal treatment and concurrent smoking cessation therapy. Periodontal maintenance was performed every 3 months. A single calibrated examiner, blinded to smoking status, assessed periodontal clinical outcomes and applied a structured questionnaire in order to collect demographic and behavioural information. Further, expired carbon monoxide concentration were measured with a monoximeter. A pooled subgingival plaque sample was collected from the deepest periodontal pocket from each participant. The presence and quantification of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola were determined using (RT-PCR).

Timeline

Start
2010-08
Primary completion
2014-02
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Background Bupropion Small molecule 150 mg
Background Nicotine Unknown 2 mg Other
Background Nicotine Unknown 4 mg Other
Background Nicotine Unknown 15 mg Other
Background Nicotine Unknown 25 mg Other
Background Varenicline Small molecule 0.5 mg

Indications